Drugs.com MedNews
WEDNESDAY April 15, 2015, 2015 -- If genetic tests are only done on
cancer tissue, as many as half of patients may not receive the most
appropriate treatment for their cancer, a new study reports.
Cancer doctors increasingly rely on genetic testing to look for
opportunities to use treatments that target specific genetic causes of
cancer -- called targeted therapy.
But doctors often examine just the genetics -- or DNA -- of a
patient's cancerous tissue, and don't compare it against a genetic
analysis of normal tissue, explained study senior author Dr. Victor
Velculescu. He is a professor of oncology and pathology at Johns Hopkins
University School of Medicine, and co-director of the school's Cancer
Biology Program.....
http://ovariancancerandus.blogspot.com/feeds/posts/default
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.